All nonsteroidal antiinflammatory drugs (NSAIDs) inhibit neutrophil ag
gregation (homotypic cell-cell adhesion) and do so without affecting e
xpression of CD11b/CD18. Since the first step in acute inflammation is
a critical interaction between neutrophils and the vascular endotheli
um (heterotypic cell-cell adhesion), we determined whether NSAIDs dimi
nish the adherence of neutrophils to the endothelium. At antiinflammat
ory concentrations (0.5-5 mM) sodium salicylate, an NSAID that does no
t inhibit prostaglandin synthesis, inhibited stimulated but not unstim
ulated neutrophil adherence to endothelial cells (IC50 < 1 mM, P < 0.0
0001). Salicylates have previously been shown to inhibit oxidative pho
sphorylation and, predictably, sodium salicylate inhibited oxidative p
hosphorylation, as evidenced by depletion of ATP stores (875 +/- 75 pm
ol/10(6) PMN, [2.92 +/- 0.25 mM]) in stimulated (FMLP, 0.1 mu M) but n
ot resting neutrophils treated with antiinflammatory doses of sodium s
alicylate (EC(50) = 1 mM, P < 0.00001). Indomethacin and piroxicam (10
and 30 mu M) only minimally decreased ATP concentrations in stimulate
d and resting neutrophils. ATP is metabolized to adenosine, and we hav
e previously demonstrated that both endogenously released (180-200 nM)
and exogenous adenosine (IC50 = 250 nM) inhibit stimulated neutrophil
adherence to endothelial cells. To determine whether the increased me
tabolism of ATP and the resultant increase in adenosine release were r
esponsible for inhibition of neutrophil adhesion to endothelium, we de
termined whether addition of adenosine deaminase (ADA, 0.125 IU/ml), a
n enzyme that converts extracellular adenosine to its inactive metabol
ite, inosine, affected inhibition of neutrophil adhesion to endotheliu
m by stimulated neutrophils. ADA significantly reversed inhibition of
neutrophil adherence to endothelium by sodium salicylate (0.5-5 mM, P
< 0.00001). This suggests that sodium salicylate inhibits neutrophil a
dherence by increasing adenosine release. Whereas indomethacin and pir
oxicam (10-50 mu M) also inhibited stimulated neutrophil adherence to
endothelial cells, ADA did not affect their inhibition of adherence. T
hese studies demonstrate a heretofore unexpected antiinflammatory mech
anism for salicylates: salicylates increase ATP hydrolysis and thereby
enhance release of adenosine. Moreover, these data are consistent wit
h the hypothesis that NSAIDs differ from one another with respect to t
heir mechanisms of action.